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Stat5 Activation Plays a Critical Role
in Th2 Differentiation
expression of GATA-3 led to the acquisition of DNase I
hypersensitivity in the Il4/Il13 locus (Ouyang et al., 2000).
GATA-3 binds to sites 3 of the Il4 gene (Agarwal et al.,
Jinfang Zhu,* Javier Cote-Sierra,
Liying Guo, and William E. Paul
Laboratory of Immunology
National Institute of Allergy 2000) and in the Il4/Il13 intergenic region in Th2 cells
(Takemoto et al., 2000). GATA-3 binding sites were alsoand Infectious Diseases
National Institutes of Health identified within the promoters of the Il5 and Il13 genes
(Siegel et al., 1995; Kishikawa et al., 2001; Yamashita etBethesda, Maryland 20892
al., 2002).
Although GATA-3 appears to be critical for Th2 differ-
entiation, infecting cells primed under Th1 conditionsSummary
with a GATA-3-GFP-RV results in cells that have features
that differ from those of Th2 cells. GATA-3-expressingUpon TCR engagement, naive CD4 T cells differentiate
toward the Th1 or Th2 phenotype. IL-4, acting through “Th1” cells did not expand as well as conventional Th2
cells. When compared to conventional Th2 cells, aStat6, plays a major role in Th2 differentiation; IL-2
has also been reported to be essential. Here, we report smaller percent of the cells produced IL-4 upon stimula-
tion. Thus, factors other than GATA-3 appear to be in-that retroviral (RV)-mediated expression of a constitu-
tively active Stat5A mutant (STAT5A1*6) can fully re- volved in Th2 differentiation. Indeed, the growth defect
in GATA-3-expressing Th1 cells can be rescued by ex-store IL-4 production when naive CD4 T cells are primed
in the absence of IL-2. Furthermore, STAT5A1*6 expres- pression of the Stat6-inducible gene, Gfi-1 (Zhu et al.,
2002).sion causes Th2 differentiation in the absence of IL-4
or in Stat6- or IL-4R-deficient cells. Infection with In the initial reports from this laboratory describing
the in vitro differentiation of Th2 cells, IL-2 was shownSTAT5A1*6-NGFR-RV does not enhance GATA-3 ex-
pression. STAT5A1*6-NGFR-RV and GATA-3-GFP-RV to play a central role (Le Gros et al., 1990; Ben-Sasson
et al., 1990). Recently, we found that neutralization ofeach render the Il4 gene accessible, but the sites of
restriction enzyme accessibility are different. Stat5A IL-2 during Th2 priming greatly diminished subsequent
IL-4 production without affecting cell proliferation or cellbinds to HSII and HSIII sites of the Il4 gene. Coinfection
with STAT5A1*6-NGFR-RV and GATA-3-GFP-RV re- yield. GATA-3 levels were still increased, but accessibil-
ity of sites in the second intron of the Il4 gene wassults in optimal Th2 priming.
decreased. Inhibitors of the MAPK and PI3K pathways
had no effect on priming for IL-4 production, suggestingIntroduction
these IL-2-elicited signaling pathways are not involved
in IL-4 production (J. Cote-Sierra et al., submitted). SincePolarization of naive CD4 T helper cells toward the Th1
or Th2 phenotype is determined by antigen affinity for Stat5-induced transcription, which is predominantly ac-
tivated by IL-2 but not IL-4, is independent of thesethe T cell receptor, concentration of antigen, and, partic-
ularly, by the cytokine milieu (reviewed in Murphy et signaling pathways, we studied the role of Stat5 in
Th2 differentiation.al., 2000, Murphy and Reiner, 2002). IL-4, triggering the
Stat6 pathway, plays a key role in Th2 differentiation in
vitro (reviewed in Nelms et al., 1999). Stat6-independent Results
Th2 development may occur in vitro but at low efficiency
(Ouyang et al., 2000). However, in vivo Th2 responses Active Stat5A (STAT5A1*6) Restores the Capacity
may be less dependent on the IL-4/Stat6 signaling path- to Produce IL-4 in Cells Primed under Th2
way. Infection of Stat6/ mice with Schistosoma man- Conditions in the Absence of IL-2
soni (Jankovic et al., 2000) or Nippostrongylus bra- Both IL-4 and IL-2 are important for optimal acquisition
siliensis (Finkelman et al., 2000; Mohrs et al., 2001a) of IL-4-producing capacity (Le Gros et al., 1990; Ben-
results in the acquisition of the capacity of CD4 T cells Sasson et al., 1990). Recently, we found that, if cells
to produce IL-4. were cultured under Th2-inducing (IL-4, anti-IL-12, anti-
GATA-3 has been reported to be necessary and suffi- IFN) conditions but in the absence of IL-2 signaling,
cient for Th2 cytokine gene expression (Zheng and Fla- the percentage of cells that acquired IL-4-producing
vell, 1997). In vitro Th2 differentiation is correlated with capacity was greatly diminished even though there was
upregulation of GATA-3 (Ouyang et al., 1998). Ectopic no diminution in cell division. Others have reported that
GATA-3 expression in Stat6-deficient cells, stimulated cells from Stat5A-deficient mice or cells treated with
through their TCRs, induces the capacity to produce phospho-Stat5 peptide are defective in Th2 differentia-
Th2 cytokines (Ouyang et al., 1998, 2000), suggesting tion (Kagami et al., 2001; Yamashita et al., 2000).
that the upregulation of GATA-3 is a downstream event To study the role of Stat5 in Th2 differentiation, a
in the IL-4/Stat6 signaling pathway. Ouyang et al. re- constitutively active mutant of Stat5A (STAT5A1*6,
ported that the IL-4-producing Stat6/ cells express Onishi et al., 1998) was introduced into CD4 T cells from
elevated levels of GATA-3 and that retroviral-mediated 5C.C7/Rag2/ (line 94) mice by retroviral infection. As
a control, infection with an NGFR-RV was carried out.
Because the anti-NGFR antibody does not completely*Correspondence: jfzhu@niaid.nih.gov
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expression of STAT5A1*6 does not result from the
unique features of this particular mutant, since expression
of another constitutive Stat5A mutant (STAT5AN642H,
Ariyoshi et al., 2000) had the same effect. Furthermore,
in separate experiments, when cultured in the presence
of IL-2, retroviral-induced wild-type Stat5A expression
was also capable of causing ThN-primed cells to acquire
IL-4-producing capacity, although to a somewhat less
efficient degree than the STAT5A1*6-NGFR-RV did (data
not shown). This result suggests that the strength of
Stat5 signaling determines the percentage of primed
cells that are capable of producing IL-4.
Increased cell proliferation was also observed in
STAT5A1*6-NGFR-RV-infected cells. To determine whether
this could explain their increased IL-4-producing capac-
ity, we compared the frequency of IL-4-producing cells
among those that divided one to three times and those
that divided four or more times, as determined by CFSE
dilution after STAT5A1*6-NGFR-RV infection. AlthoughFigure 1. STAT5A1*6 Restores IL-4 Production in Cells Primed un-
a larger proportion of NGFR (STAT5A1*6-expressing)der Th2 Conditions in the Absence of IL-2
“Th1” cells had undergone more than four divisions thanNaive line 94 CD4 T cells were activated with APC and PCC peptide
NGFR (STAT5A1*6-nonexpressing) Th1 cells (Figureunder Th2 conditions for 40 hr and infected with STAT5A1*6-NGFR-
2B), the percentage of IL-4-producing cells was theRV or NGFR-RV in the presence or absence of anti-IL-2. After an
additional 4 day culture under Th2 conditions, cells were washed same among STAT5A1*6-expressing cells that divided
and stimulated with PMA and ionomycin for 4 hr in the presence of more than four times and that divided one to three times
monensin. Cells were fixed, permeabilized, and stained for IL-4, (14.7% versus 17.4%). The STAT5A1*6-nonexpressing
IFN, and NGFR expression. The dot plots were gated on NGFR
cells do not produce IL-4 even in the population thatcells. Data are representative of three independent experiments.
had divided more than four times. Similar results were
obtained when cells were infected under ThN conditions
(data not shown). These results suggest that, althoughseparate  and  cells, we adopted the maximum fluo-
STAT5A1*6 promotes cell proliferation, this effect is dis-rescence intensity observed with uninfected cells as a
sociated from its effect on IL-4 production.“cutoff” to identify NGFR cells. However, it seems likely
Figure 2C shows the percentage of IL-4- and IFN-that some NGFR cells are included in the NGFR popu-
producing cells that express STAT5A1*6 as a result oflation (Figure 2A). For that reason, we only report results
retroviral infection compared to uninfected cells whenfrom NGFR cells.
cultured under ThN, Th1, or Th2 conditions. Under ThNAddition of anti-IL-2, anti-IL-2R, and anti-IL-2R an-
conditions, the percentage of IL-4-producing cells wastibodies during in vitro priming with 1 M cytochrome
dramatically greater in the STAT5A1*6-expressing cells
C peptide (PCC) and T-depleted spleen cells as APCs
(38.2% compared to 0.8%). STAT5A1*6 caused priming
under Th2 conditions reduced the percentage of IL-4-pro-
for IL-4 production even under Th1 conditions (from
ducing cells among those infected with the NGFR-RV 0.9% to 18.2%) and enhanced IL-4-producing capacity
to 19.9% from 44.3% (Figure 1). In the STAT5A1*6- of cells primed under Th2 conditions (from 26.4% to
NGFR-RV-infected cells, the percentage of IL-4 produc- 53%). Although STAT5A1*6 expression increased IFN
ers among the primed cells was restored to 43.2% in production under Th1 conditions (from 37% to 59.1%),
the absence of IL-2 signaling, suggesting that the IL-2- it did not cause IFN production under Th2 conditions.
triggered Stat5 pathway is responsible for mediating These results imply that the Stat5 pathway biases T cell
IL-2’s contribution to full Th2 polarization. In the pres- priming toward the production of IL-4.
ence of IL-2, 52.6% of the STAT5A1*6-NGFR-RV-infected To determine whether the capacity of the STAT5A1*6-
cells produced IL-4; this may be explained by the capac- NGFR-RV-infected cells to produce IL-4 is stable, the
ity of IL-2 to further enhance the phosphorylation and cells primed under Th1 and Th2 conditions in the experi-
activity of STAT5A1*6 (Onishi et al., 1998). ment illustrated in Figure 2C were further stimulated
under the same conditions (Figure 2D). Among the
STAT5A1*6 Expressing Cells Primed under ThN STAT5A1*6-expressing cells primed under Th1 condi-
and Th1 Conditions Produce IL-4 tions, 18.7% of them produced IL-4, similar to that of
Since STAT5A1*6 enhances IL-4 production by cells the cells before repriming (18.2%), suggesting the ability
primed under Th2 conditions, its function during Th1 of the STAT5A1*6-NGFR-RV-infected cell to make IL-4
(IL-12 and anti-IL-4) and ThN (anti-IL-4, anti-IL-12, and is stable. Interestingly, the increase in IFN production
anti-IFN) priming was also studied. In the cell popula- normally observed in reprimed Th1 cells was prevented
tion treated with the STAT5A1*6-NGFR-RV during Th1 by STAT5A1*6 (from 99.5% to 64.6%). Reprimed Th2
priming, 36.3% of the NGFR cells were capable of cells did not produce significant amounts of IFN in the
making IL-4 (Figure 2A, right panel). Among NGFR- presence of STAT5A1*6, further supporting the idea that
expressing cells infected with control NGFR-RV, only enhanced Stat5 signaling preferentially benefits Th2 but
0.8% produced IL-4 (Figure 2A, left panel). IL-4-indepen- not Th1 differentiation. Repriming of Th2 cells derived
from uninfected cells or from cells infected with thedent priming for IL-4 production caused by retroviral
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Figure 3. Stat6/ and IL-4R/ Cells Infected with STAT5A1*6-
NGFR-RV Produce IL-4
(A) Stat6/ or / C57BL/6 CD4 T cells were activated with APC
and soluble anti-CD3/anti-CD28 under ThN, Th1, or Th2 conditions
for 40 hr.
(B) Naive IL-4R/ or / DO11.10 Rag2/ CD4 T cells were acti-
vated with APC and OVA peptide under ThN or Th2 conditions for
40 hr.
A portion of the cells were infected with the STAT5A1*6-NGFR-RV
(St5); the remainder of the cells were not infected (un). After an
additional 4 day culture under continuous ThN, Th1, orTh2 condi-
tions, IL-4 production and NGFR expression was determined in
cells stimulated with PMA and ionomycin. The percentage of IL-4-
producing cells in the STAT5A1*6-NGFR-RV-infected group was
calculated based on the proportion of NGFR cells.
STAT5A1*6-NGFR-RV led to similar proportions of IL-4-
producing cells (65.2% versus 67.7%), implying that the
effect of endogenous Stat5 signaling in such cells is
already maximal.
Stat6- and IL-4R-Deficient Cells Produce IL-4
in the Presence of STAT5A1*6
Since anti-IL-4 (10 g/ml) is present when cells are cul-
Figure 2. Cells Infected with STAT5A1*6-NGFR-RV under ThN or
tured under ThN or Th1 conditions, STAT5A1*6 causingTh1 Conditions Produce IL-4
the acquisition of IL-4-producing capacity implies that(A) C57BL/6 CD4 T cells were activated with APC and soluble anti-
its effects are IL-4 independent. To establish whetherCD3/anti-CD28 under Th1 conditions for 40 hr and infected with
this is indeed the case, CD4 T cells from Stat6- andSTAT5A1*6-NGFR-RV or NGFR-RV. They were then cultured for an
additional 4 days under Th1 conditions. IL-4R-deficient mice (Kaplan et al., 1996; Noben-Trauth
(B) Line 94 CD4 T cells were activated with APC and PCC under et al., 1997) were utilized. STAT5A1*6 caused priming
Th1 conditions for 40 hr and infected with STAT5A1*6-NGFR-RV. for IL-4 production under both ThN and Th1 conditions
They were then labeled with CFSE 24 hr later and cultured for an
in Stat6/ cells (40.2% and 30.8%) just as it did inadditional 3 days under Th1 conditions.
Stat6/ cells (42.8% and 35.3%, Figure 3A). STAT5A1*6(C) Line 94 CD4 T cells were activated under ThN, Th1, or Th2
also increased IL-4 production to 41.9% under Th2 con-conditions for 40 hr. A portion of the cells were infected with the
STAT5A1*6-NGFR-RV (St5); the remainder of the cells were not in- ditions in Stat6/ cells, although this was lower than
fected (un). They were then cultured for an additional 4 days under
continuous ThN, Th1, or Th2 conditions.
(D) STAT5A1*6-NGFR-RV infected or noninfected cells primed under
Th1 or Th2 conditions, prepared in (C), were further activated under The percentage of cytokine-producing cells in the STAT5A1*6-
continuous Th1 or Th2 conditions for an additional 4 days after a 2 NGFR-RV-infected group was calculated based on the proportion
day culture in IL-2-containing medium. of NGFR cells that stained for IL-4 and/or IFN.
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Figure 4. Cells Infected with the STAT5A1*6-
NGFR-RV under ThN or Th1 Conditions Do
Not Express High Levels of GATA-3
Line 94 CD4 T cells were activated under ThN,
Th1, or Th2 conditions for 40 hr. A portion of
the cells were infected with the STAT5A1*6-
NGFR-RV (St5); the remainder of the cells
were not infected. After an additional 4 day
culture under ThN, Th1, or Th2 conditions,
cells were sorted based on the staining for
NGFR (St5).
(A) Sorted cells were then restimulated with
PMA and ionomycin for 2 hr, and real-time
RT-PCR for GATA-3 and T-bet mRNA was
carried out. Relative amounts of GATA-3 in
Th1 cells and T-bet in Th2 cells are assigned
a value of 1.
(B) Intracellular staining for GATA-3 was car-
ried out.
Similar results were obtained in two indepen-
dent experiments.
was achieved under Th2 conditions in wild-type cells has been reported to be associated with Th1 differentia-
tion and critical for IFN production in CD4 T cells(61.9%). Noninfected Stat6/ cells primed under ThN
and Th2 conditions also developed some IL-4-produc- (Szabo, et al., 2000, 2002). To study whether STAT5A1*6-
induced IL-4-producing capacity is also GATA-3-depen-ing cells (11.6% and 13.6%), although considerably
fewer than cells that had been infected with the dent, quantitative RT-PCR analysis was carried out. As
expected, cells differentiated under Th2 conditions ex-STAT5A1*6-NGFR-RV. Whether this reflects fully in vitro
priming or the prior existence of cells primed to be Th2 pressed 4-fold and 10-fold greater levels of GATA-3
mRNA than did ThN and Th1 cells, respectively (Figurecells in vivo has not been resolved. Ouyang and col-
leagues (2000) have previously reported the presence 4A). Th1 cells expressed6–8 fold higher levels of T-bet
mRNA than did ThN or Th2 cells. STAT5A1*6 expressionof Th2 cells after in vitro priming of cells from naive
Stat6/ donors. did not enhance GATA-3 mRNA level in ThN- or Th1-
primed cells; indeed, GATA-3 mRNA levels in theTo test the responsiveness of naive cell populations
lacking the capacity to respond to IL-4, we utilized CD4 STAT5A1*6-NGFR-RV-infected cells were lower than in
noninfected cells. T-bet expression was significantly in-T cells from mice transgenically expressing TCR specific
for an ovalbumin peptide (OVA) in association with I-Ad hibited by the STAT5A1*6-NGFR-RV infection in cells
primed under Th1 conditions to a level similar to that(DO11.10) that were also Rag2/ and IL-4R/. Among
the STAT5A1*6-NGFR-RV-infected DO11.10/Rag2// in Th2 cells. GATA-3 protein levels were analyzed by
intracellular staining. Th2 cells express the highest levelsIL-4R/ cells primed under ThN or Th2 conditions,
22% and 20.8% of them were capable of producing IL-4, of GATA-3; ThN cells express higher levels of GATA-3
than do Th1 cells. Infection of STAT5A1*6-NGFR-RVrespectively (Figure 3B). Among uninfected IL-4R/
cells, only 1.1% of ThN and 3% of Th2 cells expressed does not enhance GATA-3 expression either under ThN
or Th1 conditions (Figure 4B).IL-4-producing capacity. Again, the percentage of IL-4
producers from DO11.10/Rag2//IL-4R/ cells primed
under Th2 conditions was higher than that from the
STAT5A1*6-Expressing Cells Also Make Other
IL-4R/ cells even in the presence of STAT5A1*6 (57%
Th2 Cytokines
versus 20.8%). The results above indicate that enhanced
In addition to IL-4, Th2 cells produce several other cyto-
Stat5 signaling can induce IL-4 production independent
kines, including IL-5, IL-9, IL-10, and IL-13. The GATA-
of IL-4 signaling. However, optimal in vitro Th2 differenti-
3-GFP-RV- and the STAT5A1*6-NGFR-RV-infected cells
ation requires both IL-2 and IL-4 signaling.
primed under ThN conditions were equally capable of
producing all the Th2 cytokine mRNAs, including IL-4,
IL-5, IL-9, IL-10, and IL-13, after stimulation (Figure 5,STAT5A1*6 Does Not Cause an Increase
in GATA-3 Expression Level lanes 3 and 4). The amounts of cytokine mRNAs ex-
pressed by these cells were similar to those seen inGATA-3 plays a critical role in IL-4-mediated Th2 differ-
entiation (Zheng and Flavell., 1997). Stat6-independent stimulated conventional Th2 cells (Figure 5, lane 10).
Under Th1 conditions, GATA-3 had the same effect onin vitro Th2 differentiation has been reported to be corre-
lated with high GATA-3 levels (Ouyang et al., 1998). T-bet the Th2 cytokine mRNAs (Figure 5, lane 7). However, only
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primed under Th1 or ThN conditions raised the question
of whether these proceeded by independent pathways
or whether one was “upstream” of the other. Coinfection
with both RV resulted in a larger proportion of IL-4-
producing cells (64.5% for Th1; 77% for ThN) than infec-
tion with the STAT5A1*6-NGFR-RV (12.5% for Th1;
50.9% for ThN) or GATA-3-GFP-RV (28.7% for Th1;
37.8% for ThN), respectively (Figures 6A and 6B). The
MFI (mean fluorescence intensity) of IL-4-producing
cells also achieved its optimal levels in the presence of
both GATA-3 and STAT5A1*6 (Figure 6C). These results
suggest that Stat5A and GATA-3 cause IL-4 production
through nonoverlapping mechanisms.
Several regions of the Il4/Il13 locus, including DNase
I hypersensitivity sites II and III in intron 2, DNase I
hypersensitivity sites 3 of the Il4 gene (V and activation-
induced hypersensitivity site VA) and CNS1, show in-
creased accessibility during Th2 differentiation (Agarwal
and Rao, 1998; Agarwal et al., 2000; Loots et al., 2000).
CNS-1 and V/VA have been shown, genetically, to regu-
late IL-4 expression (Loots et al., 2000, Mohrs, et al.
2001b; Solymar et al., 2002). Using a restriction endonu-
clease accessibility assay (REA), we studied the effects
of GATA-3 and STAT5A1*6 expression on these four
sites. To minimize the effect of IL-2 activating Stat5 in
the GATA-3-GFP-RV-infected cells, the amount of IL-2
in cultures was limited by addition of anti-mouse IL-2
and 3 U/ml of human IL-2. Accessibility of the Il4 gene
was analyzed by REA in sorted cell populations express-
ing GFP, NGFR, or both. Infection with the STAT5A1*6-
NGFR-RV, but not with the GATA-3-GFP-RV, resulted
in increased accessibility at the HSII and HSIII sites in
the cells primed under Th1 conditions (Figure 7A). On
the other hand, infection with the GATA-3-GFP-RV, but
not the STAT5A1*6-NGFR-RV, resulted in accessible VAFigure 5. STAT5A1*6 and GATA-3 Have Similar but Distinct Roles
and CNS-1 sites. Infection with both retroviruses in cellsin Th1 and Th2 Cytokine Production
cultured under Th1 conditions resulted in a degree ofLine 94 CD4 T cells were activated under ThN, Th1, or Th2 conditions
REA at all four sites similar to that in Th2 cells.for 40 hr. A portion of the cells were infected with the STAT5A1*6-
NGFR-RV (St5) or the GATA-3-GFP-RV (Gata3); the remaining cells
were not infected. After an additional 4 day culture under ThN, Th1, STAT5A Binds to HSII and HSIII Sites but Not VA Site
or Th2 conditions, cells were sorted for NGFR (STAT5A1*6) or GFP To determine whether Stat5A1*6 binds to the Il4 gene
expression (GATA-3). Sorted cells were then restimulated with PMA
in the cells expressing low levels of GATA-3, a chromatinand ionomycin for 2 hr (P/I), and total RNA was prepared. RPA was
immunoprecipitation assay (ChIP) using STAT5A1*6-then carried out using the mCK-1 panel.
NGFR-RV-infected Th1 cells was carried out. Since all
the sequences from the HSII, HSIII, and VA sites of the
Il4 gene and from the SOCS3 promoter (AuernhammerIL-4 and IL-9 upregulation was observed in STAT5A1*6-
expressing Th1 cells (Figure 5, lane 8). From a longer et al., 1999), which contains two STAT binding sites
(S3PS), in the input samples are present at two copiesexposure, IL-10 and IL-13 bands were also observed
in this lane, but the IL-5 band was barely seen (data per cell as is a T-bet 3 UTR sequence that lacks a
potential Stat5 binding site, the ratios of the HSII, HSIII,not shown).
Stimulated Th2 cells expressed less IL-2 mRNA than VA, and S3PS to the T-bet sequence are assigned a value
of 1 (Figure 7B). In samples immunoprecipitated withdid ThN and Th1 cells. Interestingly, infection with
STAT5A1*6-NGFR-RV, but not with GATA-3-GFP-RV, in- anti-Stat5A, S3PS, as a positive control, was enriched
148 times relative to the T-bet sequence. Sequenceshibited both IL-2 and IFN mRNA in Th1 cells and IL-2
mRNA in ThN cells. from HSII and HSIII were enriched 93 and 58 times,
respectively, whereas the sequence from VA was onlyThese results suggest that STAT5A1*6 also causes
production of Th2 cytokines other than IL-4 and inhibits enriched eight times. In the control antibody immuno-
precipitated sample, all these sequences were at ratiosTh1 cytokines. GATA-3 and STAT5A1*6 have similar but
distinguishable effects on Th2 cytokine production. of less than three to the T-bet 3UTR sequence. A similar
degree of enrichment of sequences from HSII and HSIII
after anti-Stat5A ChIP was also observed in conven-Relative Roles of Stat5A and GATA-3 in IL-4
Production and Opening Il4 Gene tional Th2 but not Th1cells (data not shown). These re-
sults indicate that Stat5A binds to the sites near HSIIThe ability of both STAT5A1*6-NGFR-RV and GATA-3-
GFP-RV infection to induce IL-4 production in cells and HSIII, which could provide a mechanism through
Immunity
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Figure 7. STAT5A1*6 and GATA-3 Open Different Sites in the Il4
Gene
Line 94 CD4 T cells were activated under Th1 or Th2 conditions for
40 hr; Th1 cells were infected with the STAT5A1*6-NGFR-RV (St5)
or the GATA-3-GFP-RV (Gata3) or both. After an additional 4 day
culture under Th1 or Th2 conditions, cells were washed and cultured
in IL-2 for 2 days. They were then restimulated with APC and peptide
under Th1 or Th2 conditions for an additional two rounds; each
round consisted of 4 days of priming and 2 days in IL-2. Cells were
then sorted based on the staining for NGFR (STAT5A1*6) or GFP
expression (GATA-3).
(A) REAs for HSII, HSIII, CNS-1, and VA were carried out. Relative
accessibility of all sites to -actin in Th1 cells was assigned a value
of 1.
(B) STAT5A1*6-NGFR-RV-infected Th1 cells were fixed, lysed, and
sonicated. Samples were then immunoprecipitated with anti-Stat5A
or control rabbit serum. The input and precipitated DNA were puri-
fied, and the amount of DNA sequences derived from HSII, HSIII,
VA, S3PS, and T-bet 3UTR was assessed by real-time PCR. RelativeFigure 6. Coinfection with STAT5A1*6-NGFR-RV and GATA-3-GFP-
enrichment was calculated based on the amount of the sequence
RV Optimizes IL-4 Production
compared to that of the control sequence derived from T-bet 3UTR.
Line 94 CD4 T cells were activated with APC and PCC under ThN Data are representative of two similar experiments.
or Th1 conditions for 40 hr and coinfected with the STAT5A1*6-
NGFR-RV and the GATA-3-GFP-RV. After an additional 4 day culture
under ThN or Th1 conditions, they were stimulated with PMA and which Stat5A mediates Il4 gene accessibility and partici-
ionomycin. Staining for IL-4 and for NGFR expression was carried
pates in the induction of IL-4 production after TCR stim-out.
ulation.(A) Dot plots were gated on NGFR (St5-NGFR) and NGFR (St5-
NGFR) populations.
(B) Percent of IL-4-producing cells in each infected group was calcu- Discussion
lated.
(C) MFIs of IL-4 from positive cells in each group are presented. GATA-3 plays a major role in Th2 differentiation (Zheng
Data are representative of two similar experiments.
and Flavell, 1997). It is highly expressed in Th2 cells,
and infection with a GATA-3-GFP-RV leads to the gener-
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ation of Th2 cells in the absence of IL-4/Stat6 signaling. produce IL-4 when cultured in the presence of anti-IL-4;
the strength of Stat5 signaling correlated with the per-The upregulation of GATA-3 during the early stage of
Th2 differentiation appears to be IL-4/Stat6 dependent, centage of IL-4 producers observed in the primed cell
population. The cell proliferation rate is also enhancedbut thereafter GATA-3 may maintain its expression by
autoregulation (Ouyang et al., 1998, 2000). Whether by STAT5A1*6; however, this effect seems to be dissoci-
ated with its effect on IL-4 production, since IL-4-pro-GATA-3 transcription is directly or indirectly regulated
by Stat6 has not been determined. Furthermore, since ducing capacity was similar in cells that divided one to
three times and those that divided more than four times.GATA-3 and Gfi-1, a Stat6 inducible factor, exert a syner-
gistic effect on cell growth, GATA-3-expressing cells Infection with the STAT5A1*6-NGFR-RV did not result
in increased GATA-3 levels in cells primed under ThNmay be selected by IL-4 stimulation (Zhu et al., 2002).
The role of IL-2 in Th2 differentiation had not been or Th1 conditions. When CD4 T cells were primed under
Th2 conditions in the presence or absence of IL-2,carefully studied until recently. Although IL-2 was found
to be needed for optimal induction of IL-4-producing GATA-3 levels were similar (J. Cote-Sierra et al., submit-
ted). In addition, Cote-Sierra found that IL-2 but not IL-4cells in the initial reports of requirements for obtaining
IL-4 production (Le Gros et al., 1990; Ben-Sasson et signal can be delayed by 2 days in a 4 day Th2 priming
culture without affecting the percentage of IL-4 produc-al., 1990), its importance as a growth factor raised the
possibility that, without it, IL-4-producing cells or their ers. These results suggest that GATA-3 is not down-
stream of Stat5 signaling. Cells infected with a GATA-3-precursors might simply fail to grow. We have now found
that CD4 T cells primed under Th2 conditions, but in GFP-RV and primed under Th1 conditions did not
display enhanced Stat5 tyrosine phosphorylation in re-the presence of anti-IL-2 antibodies, produce signifi-
cantly less IL-4 than cells grown in the presence of sponse to IL-2 (data not shown), suggesting that Stat5
signaling is not “downstream” of GATA-3. Thus, Stat5IL-2. This effect does not appear to reflect diminished
expansion of IL-4-producing cells, since cell yields in and GATA-3 independently participate in priming for
IL-4 production.the absence of IL-2 and CFSE profiles of the stimulated
cells are similar (J. Cote-Sierra et al., submitted). Cells infected with either the STAT5A1*6-NGFR-RV or
the GATA-3-GFP-RV under ThN conditions were capa-IL-2 activates several signaling pathways including
the Ras-MAPK, PI3K, and Stat5 pathways (reviewed in ble of transcribing a series of Th2 cytokine genes includ-
ing IL-4, IL-5, IL-9, IL-10, and IL-13. When cells wereLin and Leonard, 2000). Inhibitors of MEK and of PI3K
did not diminish the capacity of IL-2 to enhance priming primed under Th1 conditions, however, infection with
the STAT5A1*6-NGFR-RV was less effective than infec-for IL-4 production (J. Cote-Sierra et al., submitted),
suggesting that the Stat5 signaling may be important. tion with the GATA-3-GFP-RV in priming cells to tran-
scribe Th2 cytokine genes, especially IL-5. Cells infectedIL-2 directly activates Stat5A and Stat5B. T cells from
mice deficient in either Stat5A or Stat5B did not show with STAT5A1*6-NGFR-RV showed decreased tran-
scription of both IFN and IL-2 in cells primed undera dramatic change in T cell proliferation, but cells from
mice in which both have been knocked out proliferate Th1 conditions and of IL-2 in cells primed under ThN
cells. Interestingly, infection with the GATA-3-GFP-RVpoorly in response to many cytokines, including IL-2
and IL-4 (Moriggl et al., 1999a, 1999b). However, Stat5A did not have such effects. Ouyang et al. (1998) reported
that cells primed under Th1 conditions and infected withsingle deficient mice showed impaired Th2 differentia-
tion, and reconstituting Stat5A by retroviral infection a GATA-3-GFP-RV did show suppression of IFNmRNA.
This discrepancy may be explained by the difference inrestored the capacity of cells to make IL-4, suggesting
the strength of Stat5 signaling is important for Th2 polar- the time of infection. Ouyang et al. (1998) carried out
infection at 24 hr, possibly before IL-12R expressionization (Kagami et al., 2001). The impairment of in vivo
Th2 responses in Stat5A- or Stat5B-deficient mice was is induced, whereas we infected the cells after 40 hr of
priming; the additional 16 hr may have been crucial foralso reported (Kagami et al., 2000). In our report, expres-
sion of a constitutively active Stat5 (STAT5A1*6) fully Th1 development. Nonetheless, these results indicate
that GATA-3 and Stat5 have distinctive effects on therescued the deficiency in IL-4 production that is ob-
served in CD4 T cells primed in the absence of IL-2. expression of Th1 and Th2 cytokines.
We conclude that Stat5 and GATA-3 collaborate inEnhancing the activity of Stat5 by infecting cells with a
constitutively active Stat5A (STAT5A1*6) leads to the priming cells to acquire a Th2 phenotype. This is sup-
ported by the following findings. IL-2/Stat5 signaling isacquisition of the capacity to produce IL-4 in cells
primed in the absence of IL-4, i.e., under ThN or Th1 important in Th2 differentiation although GATA-3 levels
are not affected by IL-2. Enhanced Stat5 signaling re-conditions. This IL-4-independent priming for IL-4 in
vitro has been verified by utilizing CD4 T cells derived sults in a larger proportion of cells producing IL-4 and
more IL-4 per cell when priming is carried out underfrom Stat6/ or IL-4R/ mice. In addition, we have
used different conditions to determine whether this is a ThN conditions than under Th1 conditions; the for-
mer cells express higher levels of GATA-3. Cells fromgeneral phenomenon. We have utilized CD4 T cells from
three different mouse strains, B10.A, C57BL/6, or BALB/c; Stat6/ or IL-4R/ mice infected with STAT5A1*6-
NGFR-RV primed under Th2 conditions produced lesscells have been primed with either soluble anti-CD3/
anti-CD28 or a cognate peptide, such as PCC and OVA IL-4 than did wild-type Th2 cells; presumably, GATA-3
was not induced in Stat6/ or IL-4R/ cells, evenpeptide; both PMA/ionomycin and plate-bound anti-
CD3/anti-CD28 have been used for restimulation; another under Th2 conditions. A larger proportion of cells coin-
fected with the STAT5A1*6-NGFR-RV and the GATA-3-constitutively active Stat5A mutant (STAT5AN642H) and
wild-type Stat5A were also tested. In each case, cells GFP-RV produced IL-4, and individual cells produced
more IL-4 than did cells infected with either one. Increas-infected with Stat5A retrovirus acquired the capacity to
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ing the activity of one of these transcription factors may of IL-2 (data not shown), suggesting that either the regu-
reduce the requirement for the other. However, whether lation of Stat5 signaling or the sensitivity to this pathway
both GATA-3 and Stat5 are absolutely required is un- differs between Th1 and Th2 cells.
clear. This can only be resolved when conditional Stat5 Enhancing signaling through the Stat5 pathway pre-
and GATA-3 knockouts become available. pares CD4 T cells to produce Th2 cytokines upon subse-
The collaboration of GATA-3 and Stat5 in priming for quent challenge. Whether this depends upon the very
IL-4 can be explained by their distinct effects on “open- low levels of GATA-3 (less than in conventional Th1 cells)
ing” the Il4 gene. Some regions of the Il4 gene including present is not certain. By contrast, even when GATA-3
CNS-1 and VA contain GATA-3 binding sites (Takemoto is overexpressed, Stat5 activation is still required for
et al., 2000; Agarwal et al., 2000). We observed that in Th2 differentiation. Thus, any changes in the regulation
cells cultured under Th1 conditions, infected with the of Stat5 signaling pathway, including changes of IL-2,
GATA-3-GFP-RV but not with the STAT5A1*6-NGFR-RV, IL-2 receptor, Jak kinases, SOCS family proteins, and
VA and CNS-1 had increased restriction enzyme accessi- even Stat5 itself, or of other regulatory molecules such
bility. By contrast, HSII and HSIII failed to exhibit in- as Nmi, SMRT, NFB, and CREB may influence the
creased restriction enzyme accessibility in cells infected strength of Stat5 signaling and Th2 polarization process.
with the GATA-3-GFP-RV but did so in cells infected with Furthermore, since the Stat5 pathway is not dependent
the STAT5A1*6-NGFR-RV. Ouyang et al. (2000) reported on IL-4, its activation may provide a mechanism through
that GATA-3 induced HSII in developing Th1 cells; how- which IL-4-independent Th2 polarization occurs in vivo.
ever, in their system, mouse IL-2 was not neutralized, However, since we are unable to fully polarize cells to
and thus there may have been substantial Stat5-medi- the Th2 phenotype in vitro using IL-2 but neutralizing the
ated effects. Indeed, we also observed that GATA-3 IL-4 signaling pathway, we assume that a mechanism to
induced HSII in the presence of 100 U/ml of hIL-2 (data enhance the degree of Stat5 activation or to enhance
not shown). HSII and HSIII were found to be inaccessible the sensitivity of the cell to Stat5 would be needed for
to the restriction enzyme RsaI when cells were primed IL-4-independent Th2 priming.
under Th2 conditions in the absence of IL-2 (J. Cote-
Sierra et al., submitted). A Stat5 binding site (TTCATG Experimental Procedures
GAA) has been identified in intron 2 of the Il4 gene, near
Mice and Cell CultureHSII (Hural et al., 2000). Another potential Stat5 binding
5C.C7/Rag2/ (line 94) mice were obtained from Taconic. Stat6-site (TTCTAAGAA), conserved between mouse and hu-
and IL-4R-deficient mice (Kaplan et al., 1996; Noben-Trauth et al.,man, was found near HSIII. Indeed, the binding of Stat5A
1997) were maintained in the NIAID Animal Facility. Lymph node
to HSII and HSIII regions was confirmed by ChIP, which CD4 T cells were prepared as previously described (Zhu et al.,
may offer the mechanism through which Stat5 renders 2001). T-depleted APCs were prepared by incubating spleen cells
these two sites of Il4 gene accessible. The partial open- with anti-Thy1.2 and rabbit complement (Cedarlane Laboratories
Limited) at 37	C for 45 min and then irradiated at 30 Gy (3000 rad).ing of the Il4 gene by active Stat5 or GATA-3 may allow
CD4 T cells were cocultured with APC at a 1:5 ratio in the pres-limited NFAT binding and some IL-4 transcription after
ence of pigeon cytochrome C (PCC) or ovalbumin (OVA) peptide (1stimulation. Also, it may allow factors specific for other
M/ml) or anti-CD3 (1 g/ml)/anti-CD28 (3 g/ml). Human IL-2 (10regions to bind, resulting in more complete opening of U/ml) was added to all cultures, unless otherwise specified, together
the Il4 gene. When both active Stat5 and GATA-3 are with different combinations of antibodies and cytokines: for ThN
present, the Il4 gene is fully accessible, and IL-4 tran- conditions, anti-IL-4 (10 g/ml), anti-IFN (10 g/ml), and anti-IL-12
scription achieves to its maximum levels. (10 g/ml); for Th1 conditions, anti-IL-4 (11B11, 10 g/ml) plus IL-
12 (10 ng/ml); for Th2 conditions, IL-4 (1000 U/ml), anti-IFN (10Cells that were cultured under Th1 conditions and
g/ml), and anti-IL-12 (10 g/ml). To block IL-2 signaling, anti-IL-2infected with the GATA-3-GFP-RV produced less IL-4
(S4B6, 20g/ml), anti-IL-2R (PC61, 20g/ml), and anti-IL-2R (TM-upon restimulation than did similarly cultured cells in-
1, 20 g/ml) were added.
fected with both the STAT5A1*6-NGFR-RV and the
GATA-3-GFP-RV. Since IL-2 is present during Th1 prim-
Preparation of Retroviral Constructs
ing, the superiority of the retrovirus combination, which MSCV-IRES-tNGFR (NGFR-RV) and pMX-puro-STAT5A1*6 were
may simulate Th2 priming, suggests that Stat5 signaling provided by Dr. W.C. Sha, University of California, Berkeley, and Dr.
may also differ between Th1 and Th2 cells. We have T. Kitamura, University of Tokyo, Japan, respectively. The NotI/
BamHI partially digested STAT5A1*6 cDNA fragment from the plas-not observed any difference in Stat5 phosphorylation
mid pMX-puro-STAT5A1*6 was cloned into the NotI/BglII site of thebetween IL-2-treated Th1 and Th2 cells. However, the
NGFR-RV to construct the STAT5A1*6-NGFR-RV. Retroviruses wereactivity of Stat5 has been reported to be influenced
packaged in the Phoenix-Eco packaging cell line (kindly providedpositively and negatively by other molecules, such as
by Dr. G. Nolan, Stanford, CA) as previously described (Zhu et al.,
Nmi and SMRT (Zhu et al., 1999; Nakajima et al., 2001), 2001). Purified naive CD4 T cells (5
 105) were activated with peptide
and other signaling pathways, such as the NFB path- or anti-CD3/anti-CD28 in the presence of APC in 6-well plates under
way and the cAMP pathway (Mora et al., 2001, Hinz et ThN, Th1, or Th2 conditions in 5 ml of medium and infected with
retroviruses at 40 hr after initiation of culture, as previously de-al., 2002; Boer et al., 2002), which may be activated
scribed (Zhu et al., 2001).differentially in the two cell types. Alternatively, signaling
pathway(s) elicited in Th2 cells, but not Th1 cells, may
Flow Cytometry Analysis and Intracellular Stainingincrease the sensitivity of cells to Stat5 signaling. In-
NGFR expression of infected cells was determined by staining withdeed, we have observed that Gfi-1 can cooperate with
biotin-anti-human NGFR (Pharmingen) followed by streptavidin-
Stat5 in cell proliferation in response to IL-2 (J.Z. et APC or streptavidin-Cy-Chrome. Cells were labeled with CFSE as
al., unpublished data). Furthermore, cells infected with previously described (Zhu et al., 2002). Cytosolic IL-4 or IFN content
STAT5A1*6-NGFR-RV grow much better under Th2 con- in stimulated cells was determined as previously described (Zhu et
al., 2001). Protein levels of GATA-3 were assessed by intracellularditions than those under Th1 conditions in the absence
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staining with antibody to GATA-3 (Santa Cruz, HG3-31) or control Systems) or normal rabbit serum at 4	C overnight. After deproteina-
tion and reversal of crosslinks, amounts of selected DNA sequencesmouse IgG1 followed by Cy5-anti-mouse IgG. Cells expressing ret-
roviral GATA-3 and/or Stat5A were sorted based on GFP expression were assessed by real-time PCR. The sequences of the primers and
MGB probe for HSII are 5-AAACACATGACTTGGCTATGCTGTA-3,and/or NGFR staining.
5-AGGTCTTTGTTCCTGACCTCATGT-3, and 5-FAM-TCATGGAAA
CACACCAC-3, respectively. The sequences of the primers andRNase Protection Assay and Quantitative RT-PCR
MGB probe for HSIII are 5-GGTTGCAAGGCAAGCACTCT-3, 5-Total RNA was isolated using TRIzol (Invitrogen). RNase protection
TCCTATCCCTACTACAGTTCT-3, and 5-FAM-ACAGTGCCTCATCassays (RPAs) were carried out according to the manufacturer’s
TAG-3, respectively. The sequences of the primers and MGB probeprotocol (Pharmingen) using the multiprobe template set mCK-1.
for VA are 5-AACATTGCTAGTGGCAAAGAAAG-3, 5-CAGTGCFirst-strand cDNAs were made using the SuperScript Preamplifica-
CACAATGATTGTGAATG-3, and 5-FAM-TTCCTGCAGTAGCTG-3,tion System (Invitrogen). Quantitative real-time PCR was carried out
respectively. The sequences of the primers and MGB probe foron a 7900HT sequence detection system (Applied Biosystems). The
S3PS (positive control) are 5-CACAGCCTTTCAGTGCAGAGTAGT-sequences of the primers and MGB probe for GATA-3 are 5-CAG
3, 5-AGCGGGCGAGTGTAGAGTCA-3, and 5-FAM-CGGGCAGTAACCGGCCCCTTATCA-3, 5-CATTAGCGTTCCTCCTCCAGA-3,
TCCAGGAA-3. The sequences of the primers and MGB probe forand 5-FAM-CGAAGGCTGTCGGCA-3, respectively. The sequences
T-bet 3UTR (negative control) are 5-GAGTGTCCCCTGCCCCTTT-3,of the primers and MGB probe for T-bet are 5-GAGTGTCCCC
5-TCCCTCTGGGTCCAAAACTCT-3, and 5-FAM-CTGCCCGAACTTGCCCCTTT-3, 5-TCCCTCTGGGTCCAAAACTCT-3, and 5-FAM-
ACA-3, respectively.CTGCCCGAACTACA-3, respectively. The TaqMan Ribosomal RNA
Control Reagents for detecting the 18S ribosomal RNA (VIC MGB
AcknowledgmentsProbe) were purchased from PE Applied Biosystems.
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